Our study suggests that both plasma Lp(a) and t-PA are associated with increased ASCVD risk independent of LDL levels, and were increased in very high risk patients and high risk patients who do not have underlying atherosclerosis, suggesting their roles as predictors of atherosclerosis development and progression. This evidence concerns the gene LPA and atherosclerosis.